Celularity, Inc. a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert J. Hariri in 2016 and is headquartered in Florham Park, NJ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Gx Acquisition Corp - Ordinary Shares - Class A?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Gx Acquisition Corp - Ordinary Shares - Class A market cap is $65.78M.
What is the 52-week high for Gx Acquisition Corp - Ordinary Shares - Class A?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Gx Acquisition Corp - Ordinary Shares - Class A 52 week high is $8.90 as of October 13, 2025.
What is the 52-week low for Gx Acquisition Corp - Ordinary Shares - Class A?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Gx Acquisition Corp - Ordinary Shares - Class A 52 week low is $1.59 as of October 13, 2025.
What is Gx Acquisition Corp - Ordinary Shares - Class A stock price today?
Gx Acquisition Corp - Ordinary Shares - Class A stock price today is $3.05.
What was Gx Acquisition Corp - Ordinary Shares - Class A stock price yesterday?
Gx Acquisition Corp - Ordinary Shares - Class A stock price yesterday was $3.07.
What is the PE ratio of Gx Acquisition Corp - Ordinary Shares - Class A?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Gx Acquisition Corp - Ordinary Shares - Class A’s P/E ratio is -0.30.
What is the Price-to-Book ratio of Gx Acquisition Corp - Ordinary Shares - Class A?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Gx Acquisition Corp - Ordinary Shares - Class A P/B ratio is 1.9336.
What is Gx Acquisition Corp - Ordinary Shares - Class A's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Gx Acquisition Corp - Ordinary Shares - Class A's EBITDA is -1.17.
What is the 50-day moving average of Gx Acquisition Corp - Ordinary Shares - Class A?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Gx Acquisition Corp - Ordinary Shares - Class A 50-day moving average is $4.63.
